Dementia News and Research

Latest Dementia News and Research

New biosensor system derived from E. coli bacteria could accelerate drug development

For more affordable, sustainable drug options than we have today, the medication we take to treat high blood pressure, pain or memory loss may one day come from engineered bacteria, cultured in a vat like yogurt.

7 Jul 2022

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

DZNE and Intravacc B.V., a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines, have been awarded a funding of € 2.5 million from the European Union (EIC Transition Grant) to further develop a prototype ALS vaccine, including process development, scale-up, and toxicology study.

6 Jul 2022

Scientists offer a set of recommendations to improve future research on diet and dementia

Anyone searching the internet for brain-healthy foods will find no shortage of stories making dietary recommendations. Some of those stories point to observational studies that have suggested a link between the lower or greater intake of certain foods and the risk of dementia.

5 Jul 2022

Influenza vaccination may provide protective effect against Alzheimer’s disease

Researchers compared Alzheimer's Disease development risks among recipients and non-recipients of intramuscularly administered influenza vaccines.

5 Jul 2022

Scientists prove the “neuroprotective” function of p62 protein in a mouse model

Neurodegenerative diseases like Alzheimer’s and Parkinson’s are defined by pathogenic accumulation of toxic proteins in the brain.

1 Jul 2022

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

A new study examined electronic health records for approximately half the population of Denmark, looking for people with a diagnosis of COVID-19 or hospitalized with community-acquired pneumonia.

30 Jun 2022

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Scientists have provided a detailed overview on the long-term symptoms experienced by COVID-19 patients after initial primary infection with SARS-CoV-2.

30 Jun 2022

Key protein α-synuclein linked to inflammation and Parkinson's disease

Currently, there are no disease modifying therapies for Parkinson's disease that can change the progression of the disease. An international team of scientists led by faculty at the University of Colorado Anschutz Medical Campus is hoping to change that.

30 Jun 2022

Study uncovers new gene that increases Alzheimer's disease risk in women

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S. Scientists have discovered some genetic variants that increase the risk for developing Alzheimer's; the most well-known of these for people over the age of 65 is the APOE ε4 allele.

30 Jun 2022

The effects and mechanisms of SARS-CoV-2 on the nervous system

Researchers reviewed the neurologic manifestations associated with SARS-CoV-2.

30 Jun 2022

Study finds more of white matter hyperintensities in postmenopausal women

Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a new study published in the June 29, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Jun 2022

Brain MRIs and genetics may be used to predict the chances of developing Alzheimer's disease

Simon Fraser University researchers are studying how a combination of genetics and brain MRIs may be used to predict the chances of developing Alzheimer's disease in the future.

29 Jun 2022

Sleep turns out to be a significant factor for maintaining cardiovascular health

Sleep duration is now considered an essential component for ideal heart and brain health. Life's Essential 8™ cardiovascular health score replaces Life's Simple 7™, according to a new Presidential Advisory, Life's Essential 8-;Updating and Enhancing the American Heart Association's Construct on Cardiovascular Health, published today in Circulation, the Association's flagship, peer-reviewed journal.

29 Jun 2022

Determining people with cognitive impairments based on their drawing behaviors

Changes in drawing traits have been reported in people with early-stage cognitive impairments, but most studies have used a single drawing task only.

29 Jun 2022

OpenSAFELY-TPP data is broadly representative of the English population

Researchers evaluated the representativeness of the OpenSAFELY-TPP data to the general English population

28 Jun 2022

APOEε4 may confer increased risk for CTE-related neuropathological outcomes among older adults with repetitive head impacts

How could two individuals who both played football for 10 years and developed CTE have different disease severity? How could some individuals develop dementia in their 50's while other never develop dementia at all? Perhaps the answer lies in their genes.

27 Jun 2022

Simple scan can reveal if people are at increased risk of late-life dementia

Late-life dementia is becoming increasingly common in people after 80 years of age.

27 Jun 2022

Canadian Consortium on Neurodegeneration in Aging launches an online program to prevent dementia

Canada's largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), has launched an innovative online program that offers older adults the opportunity to increase their knowledge of dementia, improve lifestyle risk factors and engage with researchers.

27 Jun 2022

The association between handgrip strength and dementia risk in a UK population of middle-aged adults

Researchers analyzed the correlations between HGS, dementia, and neurocognitive outcomes among males and females from the United Kingdom.

27 Jun 2022

Study underscores the strong protective effect of flu vaccine against Alzheimer's disease

People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer's disease over the course of four years, according to a new study from UTHealth Houston.

24 Jun 2022

Dementia News and Research

Latest Dementia News and Research

New biosensor system derived from E. coli bacteria could accelerate drug development

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

Scientists offer a set of recommendations to improve future research on diet and dementia

Influenza vaccination may provide protective effect against Alzheimer’s disease

Scientists prove the “neuroprotective” function of p62 protein in a mouse model

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Key protein α-synuclein linked to inflammation and Parkinson's disease

Study uncovers new gene that increases Alzheimer's disease risk in women

The effects and mechanisms of SARS-CoV-2 on the nervous system

Study finds more of white matter hyperintensities in postmenopausal women

Brain MRIs and genetics may be used to predict the chances of developing Alzheimer's disease

Sleep turns out to be a significant factor for maintaining cardiovascular health

Determining people with cognitive impairments based on their drawing behaviors

OpenSAFELY-TPP data is broadly representative of the English population

APOEε4 may confer increased risk for CTE-related neuropathological outcomes among older adults with repetitive head impacts

Simple scan can reveal if people are at increased risk of late-life dementia

Canadian Consortium on Neurodegeneration in Aging launches an online program to prevent dementia

The association between handgrip strength and dementia risk in a UK population of middle-aged adults

Study underscores the strong protective effect of flu vaccine against Alzheimer's disease

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in